<TABLE> <S> <C>

<ARTICLE>                                  5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS INCLUDED IN THE FORM 10-QSB OF ENDOGEN, INC. TO WHICH THIS
EXHIBIT IS A PART AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                                      0000894020
<NAME>                                     Endogen, Inc.
<MULTIPLIER>                               1,000
<CURRENCY>                                 U.S. Dollars
       
<S>                                        <C>
<PERIOD-TYPE>                              6-mos
<FISCAL-YEAR-END>                          May-31-1998
<PERIOD-START>                             Jun-01-1997
<PERIOD-END>                               Nov-30-1997
<EXCHANGE-RATE>                                                    1.00
<CASH>                                                              741
<SECURITIES>                                                          0
<RECEIVABLES>                                                     1,470
<ALLOWANCES>                                                         50
<INVENTORY>                                                       2,002
<CURRENT-ASSETS>                                                  4,644
<PP&E>                                                            3,747
<DEPRECIATION>                                                    1,454
<TOTAL-ASSETS>                                                    7,778
<CURRENT-LIABILITIES>                                             1,489
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                             34
<OTHER-SE>                                                        6,110
<TOTAL-LIABILITY-AND-EQUITY>                                      7,778
<SALES>                                                           4,914
<TOTAL-REVENUES>                                                  4,914
<CGS>                                                             1,779
<TOTAL-COSTS>                                                     4,510
<OTHER-EXPENSES>                                                      0
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                    6
<INCOME-PRETAX>                                                     398
<INCOME-TAX>                                                        132
<INCOME-CONTINUING>                                                 266
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                        266
<EPS-PRIMARY>                                                       .07
<EPS-DILUTED>                                                       .07
        

</TABLE>